Diego A. Díaz García/X
Jun 15, 2025, 02:50
Diego A. Díaz García Highlighted JAMA Article on Testicular Germ Cell Tumors and Survivorship
Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X:
“Testicular cancer is the most common solid tumor in young men (15–40y), with >90% being germ cell tumors (GCTs).
Early diagnosis + tailored treatment = excellent outcomes (5y OS: 99% in stage I).
Survivorship matters: fertility, CV risk and QoL must guide care.”
Title: Testicular Germ Cell Tumors
Journal: JAMA
Authors: Nirmish Singla, Aditya Bagrodia, Ezra Baraban, Christian D. Fankhauser, Yasser M. A. Ged
More posts featuring Diego A. Díaz García on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38